INDmoney
Incyte Corporation Stock Performance
as on February 7, 2026 at 7:59 am IST
Day's Low
Day's High
$103.64$108.52
4.39%
Downside
0.11%
Upside
52 Week's Low
52 Week's High
$53.56$112.2950.59%
Downside
3.59%
Upside
Incyte Corporation share price movements today
- Previous Close
- $102.76
- Open
- $103.75
- Volume
- 1.8M
- Day's Low - High
- $103.64 - $108.52
- 52 Week Low - High
- $53.56 - $112.29
Incyte Corporation Historical Returns
- 1 Month Return
- + 1.42 %
- 3 Month Return
- + 2.27 %
- 1 Year Return
- + 46.22 %
- 3 Year Return
- + 33.42 %
- 5 Year Return
- + 21.16 %
Incyte Corporation Stock Fundamentals & Key Indicators
Check Incyte Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$20.1B
EPS (TTM)
6.7524
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
2.91%
PE Ratio (TTM)
17.39
Industry PE ratio
21.38168831168831
PEG Ratio
0.1334
EBITDA
1.3B
Revenue (TTM)
4.8B
Profit Margin
24.70%
Return On Equity TTM
30.39%
Incyte Corporation Stock Valuation
Track how Incyte Corporation P/E has moved over time to understand its valuation trends.
Incyte Corporation in the last 5 years
Lowest (13.04x)
September 30, 2025
Today (17.39x)
February 9, 2026
Industry (21.38x)
February 9, 2026
Highest (151.83x)
September 30, 2024
Today’s Price to Earnings Ratio: 17.39x
Incyte Corporation vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Incyte Corporation with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $20.1B | 21.16% | 17.39 | 24.70% | |
| BUY | $122.3B | 123.52% | 33.56 | 31.35% | |
| BUY | $47.7B | 95.74% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 60.09% | 18.28 | 32.13% |
Stock Returns calculator for Incyte Corporation Stock including INR - Dollar returns
The Incyte Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Incyte Corporation investment value today
Current value as on today
₹1,49,752
Returns
₹49,752
(+49.75%)
Returns from Incyte Corporation Stock
₹46,230 (+46.23%)
Dollar Returns*
₹3,522 (+3.52%)
Analyst Recommendation on Incyte Corporation Stock
Based on 29 analysts
55.17%
Buy
44.83%
Hold
0.00%
Sell
Based on 29 analysts, 55.17% of analysts recommend a 'BUY' rating for Incyte Corporation. Average target price of $104.23
Incyte Corporation Share Price Target
Get share price movements and forecasts by analysts on Incyte Corporation.
What analysts predicted
-4%DOWNSIDE
Target Price
$104.23
Current Price
$108.4
Analyzed by
29 Analysts
Target
$104.23
Incyte Corporation target price $104.23, a slight downside of -4% compared to current price of $108.4. According to 29 analysts rating.
Incyte Corporation Stock’s Investor Sentiment and Interest
Search interest for Incyte Corporation Stock has increased by 116% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:116% versus previous 30 day period
Incyte Corporation Quarterly Profit & Loss
All numbers in Millions USD
Incyte Corporation Annual Profit & Loss
All numbers in Millions USD
Incyte Corporation Quarterly Cash Flow
All numbers in Millions USD
Incyte Corporation Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Incyte Corporation Stock
Check out the Mutual Funds with significant holdings in Incyte Corporation.
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.02777% | 1284 |
Global Institutional Holdings in Incyte Corporation
Incyte Corporation News & Key Events
Today's Timeline - 06 February
Fri, 03:35 PM
-Incyte receives positive CHMP opinion for Zynyz in anal canal cancer treatment, indicating potential growth opportunities.
Fri, 06:53 PM
-Incyte expected to surpass Q4 2025 earnings estimates, driven by strong Jakafi sales and new drug approvals.
Insights on Incyte Corporation
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, INCY stock has moved up by 5.6%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 1.05B → 1.36B (in $), with an average increase of 12.2% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 158.20M → 424.16M (in $), with an average increase of 32.7% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Beone Medicines Ltd has given 58.4% return, outperforming this stock by 12.2%
- NO EFFECT
Against Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.2% return, outperforming this stock by 8.8%
About Incyte Corporation
| Organisation | Incyte Corporation |
| Headquarters | 1801 Augustine Cut-Off, Wilmington, DE, United States, 19803 |
| Industry | Health Technology |
| CEO | Mr. William Meury |
| E-voting on shares | Click here to vote |
Key Management of Incyte Corporation
Name | Title |
|---|---|
Ms. Pamela M. Murphy | Vice President of Investor Relations & Corporate Communications |
Ms. Soni K. Basi Ph.D. | Executive VP & Chief Human Resources Officer |
Mr. James H. Lee M.D., Ph.D. | Group VP, Head of Inflammation & AutoImmunity Group |
Mr. William Meury | CEO, President & Director |
Ms. Alexis Smith | Vice President & Head of Investor Relations |
Mr. Richard A. Hoffman J.D., M.B.A. | Executive VP & General Counsel |
Mr. Michael James Morrissey | Executive VP & Head of Global Technical Operations |
Dr. Pablo J. Cagnoni M.D., Ph.D. | President and Head of Research & Development |
Dr. Steven H. Stein M.D. | Executive VP & Chief Medical Officer |
Mr. Thomas Tray | Principal Financial Officer, VP of Finance & Chief Accounting Officer |
FAQs
What is Incyte Corporation share price today?
Incyte Corporation share price today is $108.4 as on at the close of the market. Incyte Corporation share today touched a day high of $108.52 and a low of $103.64.
What is the 52 week high and 52 week low for Incyte Corporation share?
Incyte Corporation share touched a 52 week high of $112.29 on and a 52 week low of $53.56 on . Incyte Corporation stock price today i.e. is closed at $108.4,which is 3.46% down from its 52 week high and 102.39% up from its 52 week low.
What is Incyte Corporation's market capitalisation today?
Incyte Corporation market capitalisation is $0.02T as on .
How to invest in Incyte Corporation Stock (INCY) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Incyte Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Incyte Corporation Shares that will get you 0.0138 shares as per Incyte Corporation share price of $108.4 per share as on February 7, 2026 at 2:29 am IST.
What is the minimum amount required to buy Incyte Corporation Stock (INCY) from India?
Indian investors can start investing in Incyte Corporation (INCY) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Incyte Corporation stock (as per the Rupee-Dollar exchange rate as on ).
Based on Incyte Corporation share’s latest price of $108.4 as on February 7, 2026 at 2:29 am IST, you will get 0.0923 shares of Incyte Corporation. Learn more about
fractional shares .
What are the returns that Incyte Corporation has given to Indian investors in the last 5 years?
Incyte Corporation stock has given 21.16% share price returns and 23.83% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?